Office-to-residential conversion projects in the U.S. have spiked in 2025, with 70,700 new housing units in the pipeline.

JPMorgan Chase’s new headquarters in Manhattan is designed to make the 5-day return-to-office mandate more enticing, with ...

Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...

Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...

A new tower is rising in Fort Greene, and it might just win over audiophiles. In October 2023, developer Charney Companies ...

In the Triangle, office vacancies are at record highs. Some buildings, like Roxboro at Venable Center in Durham, are sitting ...

A new report from Gensler and the Pew Charitable Trust proposes converting old office buildings into SRO-style housing.

CetraRuddy, a New York office, was behind the largest office-to-residential conversion project in New York City to date. 25 ...

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced positive updated data from its THIO-101 ...

It still wasn't really developing at a pace that we had anticipated for the firm,” Kacie Germano said of Zebulon.

With a market cap of $77.3 billion, Regeneron Pharmaceuticals, Inc. (REGN) is a leading biotechnology company dedicated to discovering, developing, and commercializing innovative treatments for a ...